How Minoxidil Stimulates Hair Growth in the Follicle
How does topical minoxidil stimulate hair growth at the follicle level?
Here's the part almost everyone misses: what you put on your scalp isn't the active drug yet. Your follicles have to switch it on first, and everything that follows, the longer growth phase, the thicker shaft, even the early shed, sits downstream of that one chemical step. It's also why the same bottle does very different things on two different heads.
- Local Activation: Sulfotransferase enzymes in the outer root sheath, mainly SULT1A1, convert minoxidil into minoxidil sulfate.
- Channel Opening: The sulfate opens ATP-sensitive potassium channels on dermal papilla and root sheath cells.
- Brake Released: The membrane hyperpolarises, calcium influx drops, and keratinocytes keep dividing instead of shutting down.
- Cycle Shift: Resting follicles enter anagen early, and growing ones hold anagen longer before catagen.
- Support Build-Out: Growth factor output rises and the capillary network around the bulb expands to feed a bigger hair.
Minoxidil only acts once follicular sulfotransferase converts it to minoxidil sulfate, which opens ATP-sensitive potassium channels and shifts follicles into a longer anagen phase without lowering dihydrotestosterone.
What has to happen to minoxidil chemically before a follicle can respond to it?
Sulfation is the whole ballgame. The enzyme lives inside the follicle itself, so your scalp is running its own small pharmacy: the drug diffuses in switched off, and your follicular epithelium decides how much of it gets switched on.
- Activating Enzyme: SULT1A1 in outer root sheath keratinocytes, using the sulfonate donor PAPS.
- Binding Gap: Parent minoxidil binds the potassium channel poorly; the sulfate opens it at far lower concentrations.
- Short Window: Follicular sulfate levels fall substantially within hours, which is the case for daily dosing.
- Personal Ceiling: Your own enzyme activity caps what any concentration can achieve.
Minoxidil is a prodrug activated by follicular SULT1A1, and liver sulfation barely matters to a topical dose because only a small percentage of a scalp application is absorbed systemically.
How does opening ATP-sensitive potassium channels change what follicle cells do?
Think brake, not accelerator. The channel doesn't order a follicle to grow; it takes away one of the signals telling it to stop, and that difference explains why the effect shows up as timing rather than speed.
- Channel Opens: Minoxidil sulfate opens the Kir6.x and sulfonylurea receptor complex on papilla cells and root sheath keratinocytes.
- Membrane Hyperpolarises: Potassium leaves the cell and the membrane potential drops.
- Calcium Falls: Voltage-gated calcium channels close and intracellular calcium declines.
- Division Continues: With the calcium signal down, matrix keratinocytes stay in the proliferative pool instead of switching to terminal differentiation.
Sulfonylureas such as glibenclamide close the same channel and abolish the effect in follicle culture, while unrelated openers like diazoxide and pinacidil cause hypertrichosis, which pins the mechanism to the channel rather than the molecule.
Which stage of the hair growth cycle does the drug act on, and what does it change about that stage?
Pattern loss isn't really about losing follicles, it's about anagen getting shorter with every cycle until the hair produced is too fine to count. That's the clock this drug resets, and you can see the change in the numbers.
| Cycle Measure | Untreated Scalp | On Treatment |
|---|---|---|
| Anagen duration | 2 to 6 years, shortening each cycle | Prolonged; catagen delayed |
| Telogen | Around 3 months | Shortened, with early anagen entry |
| Anagen share | 85 to 90 percent, falling in affected areas | Rising anagen to telogen ratio |
| Shaft calibre | Finer with each replacement | Growing share above 40 micrometres |
Minoxidil acts at two points in the cycle, shortening telogen to force early anagen entry and prolonging anagen in follicles already growing, which is why treated areas show a burst of activity roughly two to three months in.
What happens to the blood supply around a treated follicle?
Better circulation was the original explanation for all of this, and it turned out to be the supporting act rather than the star. You still want it, because a recovered bulb is a hungry piece of tissue that can't run on the blood supply a shrunken one needed.
- Arteriolar Relaxation: The same channel opening relaxes perifollicular smooth muscle and raises local perfusion.
- Structural Change: VEGF from papilla cells drives angiogenesis, expanding the capillary network around anagen follicles.
- Demand Driven: A terminal anagen bulb consumes far more oxygen and substrate than the miniaturised follicle it replaced.
- Systemic Caution: Absorption can lower blood pressure or cause reflex tachycardia, fluid retention and peripheral oedema.
Cultured follicles with no vasculature at all still hold anagen longer when exposed to minoxidil sulfate, so improved perfusion sustains the effect rather than causing it.
Which growth factors and signalling pathways are turned up inside a treated follicle?
Downstream of the channel, a treated follicle reads like one that's been told to build. What's just as telling is what stays quiet: nothing in this list touches the hormone driving your hair loss in the first place.
- Proliferation Signals: Papilla cells raise VEGF, hepatocyte growth factor and IGF-1, driving matrix keratinocyte division.
- Prostaglandin Balance: Synthase 1 rises, lifting prostaglandin E2 against the inhibitory prostaglandin D2 found in balding scalp.
- Anagen Switch: Stabilised beta-catenin strengthens Wnt signalling, the likeliest molecular link to the telogen-to-anagen flip.
- Survival Signals: ERK and Akt activation with a higher Bcl-2 to Bax ratio cuts apoptosis in the matrix.
Treated follicles up-regulate vascular endothelial growth factor, hepatocyte growth factor, IGF-1 and prostaglandin endoperoxide synthase 1 while leaving 5-alpha reductase and the androgen receptor untouched.
How does a miniaturised follicle physically change when it responds to treatment?
Miniaturisation shrinks the entire follicular unit, not just the hair you can see. Recovery walks that back in the same order it was lost, which is why your hair usually gets thicker and darker before you can count any more of it. The catch is that a follicle has to still be there to come back.
| Feature | Miniaturised Follicle | Recovering Follicle |
|---|---|---|
| Shaft diameter | Below about 30 micrometres | Climbing toward 60 to 90 micrometres |
| Dermal papilla | Loses cells each cycle | Regains volume |
| Bulb position | Progressively shallower in the dermis | Re-established deeper |
| Pigment and medulla | Faded or absent | Usually returns alongside calibre |
Treatment thickens hairs that already exist rather than creating new follicles, and a follicle that has fully involuted into a fibrous streamer has no papilla left to respond.
Why do some scalps respond far less than others to the same application?
Two people can use the identical product with identical discipline and land in different places, and the reasons stack in a fairly predictable order. Start with the enzyme, because that part is unique to this drug, then work outward to the things you can actually change.
Trials count any measurable increase in non-vellus hair count as a response, so the widely quoted figure of roughly forty percent showing regrowth describes a spectrum of outcomes rather than a clean split between people it works for and people it doesn't.
Why does shedding often increase during the first weeks of use?
The shed that scares people off is the mechanism working in plain sight. Telogen follicles are holding club hairs that are already detached, and forcing early anagen entry evicts them weeks ahead of schedule. Knowing which shed you're looking at is what keeps you from quitting at exactly the wrong moment.
Stopping during the shedding phase discards the follicles the drug has just pushed into a new growth phase, since the shed typically begins two to four weeks in and is self-limiting within the first two months.
How long do follicle-level changes take to show as visible hair, and what happens if treatment stops?
Biology sets this clock and you can't hurry it. Hair extrudes at roughly a centimetre a month, so even an instant cellular response takes weeks to become something you can see in the mirror, and the first growth through is fine, short and unpigmented.
- Weeks 2 to 8: The synchronised shed, as resting follicles are pushed into a new cycle.
- Around 3 months: First fine regrowth appears, too soft and pale to judge coverage by.
- 4 to 6 months: The first honest assessment of whether it's working for you.
- 12 months: The fuller picture, with gains accruing through the first year then broadly plateauing.
- After stopping: A synchronised shed at three to four months, and the untreated trajectory resumed by four to six.
Because minoxidil never altered dihydrotestosterone or follicular sensitivity to it, the scalp returns to its untreated trajectory within four to six months of stopping, making this an indefinite commitment rather than a course of treatment.
What limits how much of a topical dose actually reaches the follicle?
This is the one part of the mechanism sitting entirely in your hands, and it's routinely the weakest link. The follicular opening is the shortcut into the skin, which is why the fussy-sounding advice about where and how you apply it has real pharmacology behind it.
- Absorption Rate: Roughly one to two percent crosses intact skin; follicular openings bypass the stratum corneum directly.
- Application: Dry scalp skin in the thinning area, not the hair, with several hours before washing.
- Vehicle Trade-Off: Propylene glycol penetrates well but causes the dermatitis that drives people to quit; foam swaps it for volatile alcohol.
- Barriers: Heavy sebum, styling product or seborrhoeic scale cut down what actually gets in.
Only about one to two percent of a topical dose crosses intact skin, and abraded, inflamed or freshly microneedled scalp absorbs considerably more, which is when cardiovascular effects become a genuine rather than theoretical concern.
